Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia

Citation
R. Formankova et al., Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia, BONE MAR TR, 25(4), 2000, pp. 453-456
Citations number
11
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
Journal title
BONE MARROW TRANSPLANTATION
ISSN journal
02683369 → ACNP
Volume
25
Issue
4
Year of publication
2000
Pages
453 - 456
Database
ISI
SICI code
0268-3369(200002)25:4<453:DMOHCI>2.0.ZU;2-L
Abstract
We report a case of a 13-year-old boy who was transplanted for relapse of a cute myeloid leukemia (AML), A detailed study of hematopoietic chimerism wa s performed using polymerase chain reaction (PCR) of variable number of tan dem repeats (VNTR) at very short time intervals. We used discontinuation of post-transplant immunosuppression and donor lymphocyte infusions (DLI) in order to prevent leukemia relapse that was indicated by a progressive incre ase in autologous hematopoiesis. Despite the fact that the boy relapsed 10 months after BMT, we could see a significant influence of adoptive immunoth erapy on the mixed chimerism status during the post-transplant period.